Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
MDxHealth is a commercial-stage precision diagnostics company committed to improving the diagnosis and treatment of urological cancers, including prostate and bladder cancer. The company develops and commercializes advanced molecular diagnostic tests that provide actionable information to physicians and patients, helping to guide clinical decision-making. MDxHealth's product portfolio, including ConfirmMDx®, SelectMDx®, and MonitorMDx™, aims to address unmet medical needs in cancer diagnosis, prognosis, and surveillance. They focus on providing clinicians with tools to identify high-risk patients, reduce unnecessary invasive procedures, and personalize treatment strategies.
The US headquarters in Irvine primarily focuses on commercial operations, R&D, and clinical laboratory services for the North American market. The Belgian headquarters in Herstal houses R&D, manufacturing, and European commercial operations.
Both locations feature state-of-the-art laboratory facilities compliant with CLIA (US) and ISO (Europe) standards, supporting diagnostic testing and research. The Irvine facility is strategically located in a prominent biotech hub.
MDxHealth fosters a work culture centered on innovation, patient impact, collaboration, and scientific excellence. Employees are driven by the mission to improve cancer diagnostics and patient care.
The dual-headquarter structure allows MDxHealth to effectively serve key markets in North America and Europe, leverage diverse talent pools, and navigate different regulatory landscapes. Irvine provides access to the US healthcare market and biotech ecosystem, while Herstal offers a strong base for European operations and R&D.
MDxHealth primarily operates and markets its diagnostic solutions in North America and Europe. Its global functions include research and development, manufacturing of test kits, clinical laboratory services (performing tests on patient samples), sales, marketing, and customer support. The company leverages direct sales forces and distribution partners to reach urologists and pathologists in various countries.
15279 Alton Parkway, Suite 100 (US HQ); CAP Business Parc, Zone des Hauts Sarts, Rue d'Abhooz 31 (Belgian HQ)
Irvine (US); Herstal (BE)
California (US); Liège (BE)
USA; Belgium
Address: Microweg 1, 6545 CL Nijmegen, Netherlands
Supports European research, development, and laboratory operations, focusing on innovative molecular diagnostics for urology.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, mdxhealth' leadership includes:
mdxhealth has been backed by several prominent investors over the years, including:
MDxHealth has seen some key appointments and transitions in its leadership team over the past year, aimed at strengthening its commercial and operational capabilities. No significant high-profile exits have been widely publicized recently.
Discover the tools mdxhealth uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
MDxHealth likely utilizes common corporate email formats. Based on industry standards and observed patterns for similar companies, the most probable format is [first_initial][last_name]@[company_domain].com or [first_name].[last_name]@[company_domain].com.
f[last]@mdxhealth.com or [first].[last]@mdxhealth.com
Format
jdoe@mdxhealth.com or john.doe@mdxhealth.com
Example
85%
Success rate
MDxHealth Press Release • May 8, 2024
MDxHealth announced its financial results for Q1 2024, highlighting revenue growth driven by its prostate cancer tests and ongoing commercial expansion efforts. The company reported total revenue of $20.0 million for Q1 2024, an increase of 69% from Q1 2023....more
MDxHealth Press Release • April 2, 2024
A new study published in The Journal of Urology demonstrates that the SelectMDx for Prostate Cancer test significantly reduces the diagnosis of indolent, low-grade prostate cancer and associated over-treatment. The study underscores the test's value in guiding biopsy decisions....more
MDxHealth Press Release • October 23, 2023
MDxHealth announced the appointment of Ron Kalfus as its new Chief Financial Officer, effective October 23, 2023. Mr. Kalfus brings over 25 years of financial leadership experience in the healthcare industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including mdxhealth, are just a search away.